A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study - Gerstein, HC; Yale, JF; Harris, SB (Diabetic medicine: a journal of the British Diabetic Association, 2006)
doi:10.1111/j.1464-5491.2006.01881.x